To date, previous results on risk factors of BM in NSCLC are not completely consistent, which included non-squamous cell carcinoma [18], younger age [18-20], high serum CEA level [21], no adjuvant chemotherapy [19, 22] and various disease stages [19, 22]. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.